Mr. Robert F. Friel is an Independent Director at NuVasive, Inc., an Independent Director at Xylem, Inc., a President at PerkinElmer Life & Analytical Sciences, Inc. and a Chairman-Supervisory Board at EUROIMMUN Medizinische Labordiagnostika AG.
He is on the Board of Directors at West Pharmaceutical Services, Inc., New York Life Insurance Co., NuVasive, Inc., Xylem, Inc. and Analytical Life Science & Diagnostics Association. Mr. Friel was previously employed as an Independent Director by CareFusion Corp., a Chairman & Chief Executive Officer by PerkinElmer, Inc. (United States), a Treasurer & Vice President by Honeywell International LLC, a President & Chief Executive Officer by Excelitas Technologies Sensors, Inc., and a National Trustee by March of Dimes Foundation.
He also served on the board at Millennium Pharmaceuticals, Inc.
He received his undergraduate degree from Lafayette College and a graduate degree from Fairleigh Dickinson University.